Ernexa Therapeutics Inc.ERNANASDAQ
Loading
Asset Growth Under PressureDecelerating
Percentile Rank32
Year-over-Year Change
Year-over-year total asset growth rate
Percentile
P32
Within normal range
vs 2Y Ago
-1.7x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -18.62% |
| Q2 2025 | 49.91% |
| Q1 2025 | -3.99% |
| Q4 2024 | -31.73% |
| Q3 2024 | -83.40% |
| Q2 2024 | -6.39% |
| Q1 2024 | 1.07% |
| Q4 2023 | -5.96% |
| Q3 2023 | 11.27% |
| Q2 2023 | 210.79% |
| Q1 2023 | -32.19% |
| Q4 2022 | 6.47% |
| Q3 2022 | -22.21% |
| Q2 2022 | -23.95% |
| Q1 2022 | 12.22% |
| Q4 2021 | -19.98% |
| Q3 2021 | -39.12% |
| Q2 2021 | 212.64% |
| Q1 2021 | 60.38% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |